Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search

Comprehensive analysis of the interrelationships between somatometric, biochemical, and clinical indicators reflecting the condition of patients with chronic kidney disease

https://doi.org/10.17749/2070-4909/farmakoekonomika.2025.295

Abstract

Objective: To identify potential predictors of chronic kidney disease (CKD) based on the analysis of interrelationships between somatometric (including bioimpedance), biochemical, and clinical indicators in CKD patients.

Material and methods. The values of 58 indicators describing the condition of 357 participants were collected: 128 patients with CKD and 229 participants in the control group (without kidney pathology). Demographic, anthropometric, anamnestic data (19 diagnoses according to the International Classification of Diseases, 10th revision), bioimpedance values, results of general and biochemical blood tests (19 indicators), and diet indicators (using the CINDI survey) were studied. New mathematical approaches were applied to establish informative value intervals for numerical indicators, to find metric clusters in the multidimensional space of biomedical indicators, and to construct metric maps.

Results. In the CKD group, a predominance of older patients (mean age 54.1±13.1 years) as well as overweight people (82.18±19 kg) was observed compared to the control group (48.78±9.75 years and 74.7±17.45 kg, respectively). Patients with CKD exhibit disturbances in adipose tissue metabolism, decreased active and reactive bioimpedance resistance, high systolic blood pressure, and multiple organ pathology.

Conclusion. The analysis of the cluster of interrelationships between indicators made it possible to outline promising areas for further research. These include a more detailed investigation of informativeness and predictive strength of CKD predictors, a comprehensive assessment of treatment effectiveness, identification of differences between subgroups of patients with different nosologies and stages of CKD, evaluation of the efficacy of various therapeutic approaches, the role of physical activity, and micronutrient status.

About the Authors

I. Yu. Torshin
Federal Research Center “Computer Science and Control”, Russian Academy of Sciences
Russian Federation

Ivan Yu. Torshin, PhD (Phys. Math.), PhD (Chem.) 

WoS ResearcherID: C-7683-2018

Scopus Author ID: 7003300274

44 corp. 2 Vavilov Str., Moscow 119333



N. Z. Bashun
Yanka Kupala State University of Grodno
Belarus

Natallia Z. Bashun, PhD, Assoc. Prof.

WoS ResearcherID: JWO-3263-2024

Scopus Author ID: 22233495200

22 Ozheshko Str., Grodno 230023



O. A. Gromova
Federal Research Center “Computer Science and Control”, Russian Academy of Sciences
Russian Federation

Olga A. Gromova, Dr. Sci. Med., Prof.

WoS ResearcherID: J-4946-2017

Scopus Author ID: 7003589812

44 corp. 2 Vavilov Str., Moscow 119333



A. V. Chekel
Yanka Kupala State University of Grodno
Belarus

Anna V. Chekel

22 Ozheshko Str., Grodno 230023



A. A. Levchuk
Yanka Kupala State University of Grodno
Belarus

Alexandra A. Levchuk

22 Ozheshko Str., Grodno 230023



S. N. Lazarevich
Grodno University Clinic
Belarus

Sergey N. Lazarevich

52 Leninsky Komsomol Blvd, Grodno 230017



References

1. Bоhm A., Heitmann B.L. The use of bioelectrical impedance analysis for body composition in epidemiological studies. Eur J Clin Nutr. 2013; 67 (1): 79–85. https://doi.org/10.1038/ejcn.2012.168.

2. Zybalova T.S. Bioimpedance analysis in clinical practice. In: Trisvetova Е.L. (Ed.) Internal diseases today: collection of scientific papers dedicated to the 100th anniversary of the Belarusian State Medical University. Minsk: Kovcheg; 2021: 79–90 (in Russ.).

3. Zharnov A., Bashun N., Zharnova O., et al. Comparison of indexes of physical development biological objects measured by anthropometric and bio-impedance methods. J Hygien Engin Design. 2019; 27 (9): 120–4.

4. Carney E.F. The impact of chronic kidney disease on global health. Nat Rev Nephrol. 2020; 16 (5): 251. https://doi.org/10.1038/s41581-020-0268-7.

5. Zharnova V.V., Slizevich T.N., Chekel A.V., et al. Application of the method of vector analysis of bioimpedance for the assessment of the status of hydration in patients with diffuse liver changes. News of Medical and Biological Sciences. 2019; 19(4): 48–54 (in Russ.).

6. Gupta A., Sontakke T., Acharya S., Kumar S. A comprehensive review of biomarkers for chronic kidney disease in older individuals: current perspectives and future directions. Cureus. 2024; 16 (9): e70262. https://doi.org/10.7759/cureus.70262.

7. Sintra E., Jenny S., Wallengren O., et al. Bioimpedance analysis in patients with chronic kidney disease. J Ren Care. 2023; 49 (3): 147–57. https://doi.org/10.1111/jorc.12474.

8. Jaffrin M.Y. Body composition determination by bioimpedance: an update. Curr Opin Clin Nutr Metab Care. 2009; 12 (5): 482–6. https://doi.org/10.1097/MCO.0b013e32832da22c.

9. Torshin I.Y. Optimal dictionaries of the final information on the basis of the solvability criterion and their applications in bioinformatics. Pattern Recognit Image Anal. 2013; 23 (2): 319–27. https://doi.org/10.1134/S1054661813020156.

10. Zhuravlev Yu.I. Selected scientific works. 1st ed. Moscow: Magistr; 1998: 416 pp. (in Russ.).

11. Zhuravlev Yu.I., Rudakov K.V., Torshin I.Yu. Algebraic criteria of local solvability and regularity as a tool for studying the morphology of amino acid sequences. Proceedings of MIPT. Series 3. Physicochemical Biology. 2011; 3 (4): 67–76 (in Russ.).

12. Gromova O.A., Kalacheva A.G., Torshin I.Yu., et al. Magnesium deficiency is a reliable risk factor for comorbid conditions: results of a large-scale screening of magnesium status in the regions of Russia. Farmateka. 2013; 1 (6): 116–29.

13. Kerimkulova N.V., Nikiforova N.V., Vladimirova I.S., et al. The impact of undifferentiated connective tissue dysplasia on pregnancy and childbirth outcomes. Comprehensive examination of pregnant women with connective tissue dysplasia using data mining methods. Zemsky Vrach. 2013; 2 (19): 34–38 (in Russ.).

14. Kolmogorov A.N. Probability theory and mathematical statistics. Vol. 2. Moscow: Nauka; 2005: 581 pp. (in Russ.).

15. Smirnov N.V. Approximation of distribution laws of random variables by empirical data. Uspekhi matematicheskikh nauk. 1944; 10: 179–206 (in Russ.).


What is already known about thе subject?

Bioimpedance is a marker of morphological constitution, a kind of “mirror” for metabolic processes in the body under various pathologies

Bioimpedance assessment in clinical practice is aimed at early correction of adverse changes in body composition

Excess adipose tissue, especially visceral fat, loss of muscle mass, negative changes in fluid balance, and reduced bone density are characteristic of kidney diseases

What are the new findings?

Patients with chronic kidney disease (CKD) are characterized by older age, excess body weight (as confirmed by bioimpedance and biochemical blood tests), higher blood pressure, and multiple organ pathology

The indicator “lean mass, kg” increases monotonically with height, body weight, waist circumference, intracellular fluid, basal metabolic rate, and total body water and, conversely, decreases monotonically with increasing active resistance 5 and 50 kHz as well as reactive resistance 50 kHz

How might it impact the clinical practice in the foreseeable future?

It is promising to further investigate the informativeness and predictive strength of CKD predictors

It is important to conduct a comprehensive assessment of the effectiveness of various therapies for renal pathology in subgroups of CKD patients with different disease severity, taking into account their impact on impedance parameters

It is necessary to assess the efficacy of various therapeutic approaches, the role of physical activity and micronutrient status (if relevant data are available)

Review

For citations:


Torshin I.Yu., Bashun N.Z., Gromova O.A., Chekel A.V., Levchuk A.A., Lazarevich S.N. Comprehensive analysis of the interrelationships between somatometric, biochemical, and clinical indicators reflecting the condition of patients with chronic kidney disease. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2025;18(2):271-283. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2025.295

Views: 161


ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)